Clinical Trial: A Study to Evaluate The Long-Term Safety And Efficacy of Rozanolixizumab in Adult Participants With Ocular Myasthenia Gravis

U.S., March 12 -- ClinicalTrials.gov registry received information related to the study (NCT07465289) titled 'A Study to Evaluate The Long-Term Safety And Efficacy of Rozanolixizumab in Adult Participants With Ocular Myasthenia Gravis' on March 06.

Brief Summary: The purpose of the study is to assess the long-term safety and efficacy of rozanolixizumab in adult study participants with ocular myasthenia gravis.

Study Start Date: July 27, 2026

Study Type: INTERVENTIONAL

Condition: Ocular Myasthenia Gravis

Intervention: DRUG: Rozanolixizumab

Rozanolixizumab will be administered by subcutaneous infusion.

Recruitment Status: NOT_YET_RECRUITING

Sponsor: UCB Biopharma SRL

Disclaimer: Curated by HT Syndication....